EU-HTA

How are outcomes defined within the JCA framework?

When thinking about JCA, the focus often goes straight to the complex template, the potential high number of PICOs, and the extensive evidence requirements ...

How predictable are PICO scoping processes of the Coordination Group?

We provide you with the latest regulatory update from the EMA, announced last week ...

From 01 to 29 April 2026 the next JSC request period will open for another three JSC slots, with briefing documents to be submitted between July and September ...

Built together with our European network of local experts, the database delivers all key documents in one place, ...

Most national HTA assessment start once a product is approved. But some begin earlier ...

Pfizer has withdrawn the EU marketing authorisation application for sasanlimab, which in turn means that the associated Joint Clinical Assessment (JCA) has been discontinued ...

Real-World Evidence, RWE, often sounds like a solution to many evidence challenges ...